Corrigendum to ‘Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study’ [European Journal of Cancer 154 (2021) 246-252] (European Journal of Cancer (2021) 154(246-252) (S0959804921004044), (10.1016/j.ejca.2021.06.029))

Nicola Fazio, Lorenzo Gervaso, Thorvardur R. Halfdanarson, Anna La Salvia, Johannes Hofland, Jorge Hernando, Mohamad B. Sonbol, Rocio Garcia-Carbonero, Jaume Capdevila, Wouter W. de Herder, Anna Koumarianou, Gregory Kaltsas, Maura Rossi, Simona Grozinsky-Glasberg, Kira Oleinikov, Sabrina Boselli, Darina Tamayo, Vincenzo Bagnardi, Alice Laffi, Manila RubinoFrancesca Spada

Research output: Contribution to journalComment/debatepeer-review

Abstract

The authors regret that the world map presented in Figure 1 was incomplete. Please see the correct image for Fig 1 below. This has also been updated in the online article. [Figure presented] The authors would like to apologise for any inconvenience caused.

Original languageEnglish (US)
JournalEuropean Journal of Cancer
DOIs
StateAccepted/In press - 2021

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Corrigendum to ‘Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study’ [European Journal of Cancer 154 (2021) 246-252] (European Journal of Cancer (2021) 154(246-252) (S0959804921004044), (10.1016/j.ejca.2021.06.029))'. Together they form a unique fingerprint.

Cite this